Koshinski Asset Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.16M Sell
11,173
-673
-6% -$60.1K 0.06% 267
2026
Q1
$851K Buy
11,846
+4,175
+54% +$322K 0.05% 314
2025
Q4
$609K Buy
7,671
+814
+12% +$64.2K 0.04% 384
2025
Q3
$517K Sell
6,857
-76
-1% -$5.21K 0.03% 411
2025
Q2
$478K Buy
6,933
+2,003
+41% +$131K 0.04% 417
2025
Q1
$334K Buy
4,930
+178
+4% +$10.7K 0.03% 464
2024
Q4
$213M Sell
4,752
-141
-3% -$7.91K 0.02% 583
2024
Q3
$308K Sell
4,893
-949
-16% -$55.4K 0.03% 485
2024
Q2
$337K Sell
5,842
-1,715
-23% -$107K 0.03% 435
2024
Q1
$603K Sell
7,557
-382
-5% -$29.2K 0.06% 292
2023
Q4
$627K Buy
7,939
+663
+9% +$47.2K 0.1% 243
2023
Q3
$508K Sell
7,276
-1,401
-16% -$99.3K 0.06% 318
2023
Q2
$600K Sell
8,677
-4,235
-33% -$301K 0.06% 304
2023
Q1
$959K Sell
12,912
-821
-6% -$68.8K 0.09% 216
2022
Q4
$1.28M Buy
13,733
+592
+5% +$57.1K 0.12% 181
2022
Q3
$1.25M Buy
13,141
+946
+8% +$93.6K 0.15% 160
2022
Q2
$1.13M Sell
12,195
-2,069
-15% -$202K 0.11% 211
2022
Q1
$1.44M Sell
14,264
-175
-1% -$18.4K 0.12% 180
2021
Q4
$1.49M Buy
14,439
+926
+7% +$85.6K 0.12% 184
2021
Q3
$1.15M Buy
13,513
+4,844
+56% +$406K 0.1% 218
2021
Q2
$723K Sell
8,669
-4,675
-35% -$383K 0.09% 251
2021
Q1
$1M Buy
13,344
+623
+5% +$45.4K 0.11% 224
2020
Q4
$869K Sell
12,721
-318
-2% -$20.7K 0.11% 217
2020
Q3
$779 Sell
13,039
-439
-3% -$27.3K 0.1% 215
2020
Q2
$876K Buy
13,478
+1,665
+14% +$105K 0.14% 182
2020
Q1
$701K Sell
11,813
-200
-2% -$13.4K 0.15% 183
2019
Q4
$885K Buy
12,013
+2,015
+20% +$141K 0.15% 206
2019
Q3
$631K Buy
9,998
+2,583
+35% +$153K 0.44% 74
2019
Q2
$404K Buy
+7,415
New +$399K 0.16% 168
2019
Q1
Sell
-16,231
Closed -$1.06M 408
2018
Q4
$1.06M Sell
16,231
-1,045
-6% -$78K 0.26% 118
2018
Q3
$1.36M Buy
17,276
+6,900
+66% +$493K 0.19% 157
2018
Q2
$668K Sell
10,376
-3,886
-27% -$256K 0.2% 161
2018
Q1
$887K Sell
14,262
-5,872
-29% -$421K 0.28% 121
2017
Q4
$1.46M Buy
20,134
+5,040
+33% +$366K 0.37% 94
2017
Q3
$1.23M Sell
15,094
-2,318
-13% -$183K 0.4% 74
2017
Q2
$1.4M Sell
17,412
-4,282
-20% -$338K 0.51% 52
2017
Q1
$1.7M Buy
21,694
+9,858
+83% +$787K 0.67% 41
2016
Q4
$934K Buy
11,836
+8,825
+293% +$714K 0.46% 63
2016
Q3
$268K Sell
3,011
-407
-12% -$38.4K 0.13% 230
2016
Q2
$327K Sell
3,418
-87
-2% -$8.67K 0.18% 184
2016
Q1
$364K Buy
3,505
+530
+18% +$51.5K 0.24% 141
2015
Q4
$291K Buy
2,975
+205
+7% +$20.1K 0.2% 146
2015
Q3
$291K Buy
2,770
+356
+15% +$37.4K 0.19% 163
2015
Q2
$253K Sell
2,414
-22
-0.9% -$2.25K 0.16% 187
2015
Q1
$251K Sell
2,436
-4,493
-65% -$455K 0.16% 179
2014
Q4
$667K Buy
+6,929
New +$611K 0.38% 70

Other funds holding CVS

Koshinski Asset Management's CVS Position: Q2 2026 in Review

Koshinski Asset Management reduced its CVS Health (CVS) stake by 5.7% in Q2 2026, selling an estimated $60.1K and leaving 11,173 shares worth $1.16M. The position accounts for 0.06% of the portfolio, ranked #267.

Koshinski Asset Management first reported a position in CVS in Q4 2014 and has held it in 46 quarters since. The position peaked at $213M in Q4 2024. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Koshinski Asset Management held 11,173 shares of CVS Health worth $1.16M as of Q2 2026.
  • Koshinski Asset Management sold 673 CVS Health shares in Q2 2026, an estimated $60.1K.
  • CVS Health made up 0.06% of Koshinski Asset Management's portfolio in Q2 2026, its #267 holding.
  • Koshinski Asset Management first reported a position in CVS Health in Q4 2014 and has held it in 46 quarters since.
  • Koshinski Asset Management's CVS Health position peaked at $213M in Q4 2024.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Koshinski Asset Management's 13F filing for Q2 2026, filed 27 Jul 2026.